BAKER BROS. ADVISORS LP - 09 Dec 2025 SCHEDULE 13D/A Report for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR)

Filing Manager: BAKER BROS. ADVISORS LP
Reporting Manager: Baker Bros. Advisors LP
Security: Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: KYMR
Shares outstanding: 79,603,642 shares
Disclosed Ownership: 8,676,797 shares
Ownership: 11%
Form type: SCHEDULE 13D/A
Filing time: 11 Dec 2025, 17:27:12 UTC
Date of event: 09 Dec 2025
Previous filing: 30 Jun 2025
SEC: View on sec.gov

Key filing fact

BAKER BROS. ADVISORS LP disclosed 11% ownership in Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR) on 09 Dec 2025.

Key facts

BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR).
Disclosed ownership: 11%.
Date of event: 09 Dec 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
Baker Bros. Advisors LP	11%	8,676,797	8,676,797	/s/ Scott L. Lessing	By: Baker Bros. Advisors (GP) LLC, its general partner Scott L. Lessing/ President	0001263508
Baker Bros. Advisors (GP) LLC	11%	8,676,797	8,676,797	/s/ Scott L. Lessing	Scott L. Lessing/ President	0001580575
Julian C. Baker	11%	8,676,797	8,676,797	/s/ Julian C. Baker	Julian C. Baker	0001087939
Felix J. Baker	11%	8,676,797	8,676,797	/s/ Felix J. Baker	Felix J. Baker	0001087940

CIK / CUSIP context first

Broader feeds